Valuation: Strides Pharma Science Limited

Market Cap 97.69B 1.03B 916M 850M 774M 1.46B 1.49B 10.23B 4B 50.9B 3.86B 3.77B 163B P/E 2027 *
15.6x
P/E 2028 * 11.1x
Enterprise Value 97.69B 1.03B 916M 850M 774M 1.46B 1.49B 10.23B 4B 50.9B 3.86B 3.77B 163B EV / Sales 2027 *
1.68x
EV / Sales 2028 * 1.41x
Free-Float
68.12%
Yield 2027 *
0.28%
Yield 2028 * 0.28%
1 day-2.30%
1 week-3.70%
Current month-5.37%
1 month-10.44%
3 months-1.05%
6 months+5.87%
Current year+17.72%
1 week 1,051.3
Extreme 1051.3
1,107
1 month 1,051.3
Extreme 1051.3
1,260.9
Current year 768.65
Extreme 768.65
1,260.9
1 year 768.65
Extreme 768.65
1,260.9
3 years 467
Extreme 467
1,675
5 years 263.35
Extreme 263.35
1,675
10 years 263.35
Extreme 263.35
1,675
Manager TitleAgeSince
Chief Executive Officer - 01/06/2024
Director of Finance/CFO 42 01/06/2024
Chief Tech/Sci/R&D Officer - 21/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 18/05/2017
Director/Board Member 82 18/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.30%-3.70%+33.23%+107.74% 1.05B
+3.55%+5.29%+54.07%+105.45% 1,077B
-0.25%-2.00%+32.71%+61.48% 612B
+0.59%+4.44%+23.69%+91.54% 501B
-1.48%+1.68%+71.42%+39.59% 364B
+2.37%+5.47%+32.67%+48.87% 353B
+2.64%+4.90%+21.01%+43.85% 278B
+3.24%+4.25%-0.31%+15.71% 251B
+1.86%+5.07%+47.70%+52.77% 230B
+2.49%+7.16%+32.82%+102.67% 190B
Average +1.24%+1.62%+34.90%+66.97% 385.76B
Weighted average by Cap. +1.03%+1.58%+39.06%+71.73%

Financials

2027 *2028 *
Net sales 58.23B 613M 546M 507M 462M 869M 885M 6.09B 2.38B 30.34B 2.3B 2.25B 96.88B 69.12B 727M 648M 602M 548M 1.03B 1.05B 7.23B 2.83B 36.01B 2.73B 2.67B 115B
Net income 6.28B 66.04M 58.88M 54.64M 49.76M 93.73M 95.44M 657M 257M 3.27B 248M 243M 10.44B 8.8B 92.56M 82.53M 76.59M 69.74M 131M 134M 921M 360M 4.58B 347M 340M 14.64B
Net Debt - -
Projected Income Statement - Annual - Strides Pharma Science Limited
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
15/10/26 ₹1,059.90 -2.30% 253,392
14/10/26 ₹1,084.80 -0.98% 184,350
13/10/26 ₹1,095.50 -0.06% 304,227
12/10/26 ₹1,096.20 +1.00% 80,618
09/10/26 ₹1,085.30 -0.91% 189,136
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Strides Pharma Science Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,059.90INR
Average target price
1,338.67INR
Spread / Average Target
+26.30%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Strides Pharma Science Limited
  1. Stock Market
  2. Stocks
  3. STAR Stock